NYSE:NGVT Ingevity (NGVT) Stock Price, News & Analysis $61.93 -0.04 (-0.06%) As of 10:03 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Ingevity Stock (NYSE:NGVT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ingevity alerts:Sign Up Key Stats Today's Range$62.29▼$62.2950-Day Range$60.06▼$75.5852-Week Range$46.38▼$79.29Volume1,463 shsAverage Volume293,801 shsMarket Capitalization$2.09 billionP/E Ratio36.43Dividend YieldN/APrice Target$80.00Consensus RatingHold Company Overview Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world. The company became an independent, publicly traded business in 2016 after being spun off from WestRock.AI Generated. May Contain Errors. Read More Ingevity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreNGVT MarketRank™: 4.11517775154 of 5 starsIngevity scored higher than 82% of companies evaluated by MarketBeat, and ranked 86th out of 227 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingIngevity has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialIngevity has a consensus price target of $80.00, representing about 29.0% upside from its current price of $62.00.Amount of Analyst CoverageIngevity has only been the subject of 1 research reports in the past 90 days.Read more about Ingevity's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.26% Earnings GrowthEarnings for Ingevity are expected to grow by 9.26% in the coming year, from $5.40 to $5.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ingevity is 12.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Ingevity is 12.40, which means that it is trading at a less expensive P/E ratio than the Materials sector average P/E ratio of about 27.21.Price to Book Value per Share RatioIngevity has a P/B Ratio of 33.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.74% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 4.38.Change versus previous monthShort interest in Ingevity has recently decreased by 8.17%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIngevity does not currently pay a dividend.Dividend GrowthIngevity does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.66 News SentimentIngevity has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Materials companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Ingevity this week, compared to 2 articles on an average week. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Ingevity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $764,673.00 in company stock.Percentage Held by Insiders0.88% of the stock of Ingevity is held by insiders.Percentage Held by Institutions91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Ingevity's insider trading history. Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NGVT Stock News HeadlinesIngevity : CEO, Dave Li, to Receive the Chemists’ Club 2026 Winthrop-Sears AwardNovember 10 at 7:05 PM | marketscreener.comMIngevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?November 9, 2026 | finance.yahoo.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 13 at 1:00 AM | Porter & Company (Ad)Ingevity Corporation (NGVT) Q3 2026 Earnings Call TranscriptNovember 7, 2026 | seekingalpha.comIngevity (NGVT) Q3 2026 Earnings Call TranscriptNovember 5, 2026 | finance.yahoo.comIngevity Corporation 2026 Q3 - Results - Earnings Call PresentationNovember 5, 2026 | seekingalpha.comIngevity Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 4, 2026 | marketscreener.comMIngevity: Q3 earnings snapshotNovember 4, 2026 | msn.comSee More Headlines NGVT Stock Analysis - Frequently Asked Questions How have NGVT shares performed this year? Ingevity's stock was trading at $59.22 on January 1st, 2026. Since then, NGVT shares have increased by 4.7% and is now trading at $62.0040. How were Ingevity's earnings last quarter? Ingevity Corporation (NYSE:NGVT) released its quarterly earnings data on Wednesday, November, 4th. The company reported $1.63 earnings per share for the quarter, beating analysts' consensus estimates of $1.56 by $0.07. The company earned $305.10 million during the quarter, compared to analysts' expectations of $303.91 million. Ingevity had a trailing twelve-month return on equity of 405.38% and a net margin of 5.28%. Read the conference call transcript. Who are Ingevity's major shareholders? Top institutional shareholders of Ingevity include State Street Corp (4.26%), Royce & Associates LP (2.56%), Bessemer Group Inc. (1.34%) and Boston Partners (1.31%). Insiders that own company stock include David H Li, Ryan C Fisher and Terrance M Dyer. View institutional ownership trends. How do I buy shares of Ingevity? Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include Walt Disney (DIS), GE Aerospace (GE), Pfizer (PFE), Verizon Communications (VZ), Alphabet (GOOG), NVIDIA (NVDA) and Qualcomm (QCOM). Company Calendar Last Earnings11/04/2026Today11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NGVT's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMaterials Industry Chemicals Sub-IndustrySpecialty Chemicals Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CIK1653477 Webwww.ingevity.com Phone(843) 740-2300Fax843-740-8165Employees1,500Year Founded2015Price Target and Rating Average Price Target for Ingevity$80.00 High Price Target$83.00 Low Price Target$75.00 Potential Upside/Downside+27.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$1.70 Trailing P/E Ratio36.82 Forward P/E Ratio10.61 P/E GrowthN/ANet Income-$167.10 million Net Margins5.28% Pretax Margin3.93% Return on Equity405.38% Return on Assets11.41% Debt Debt-to-Equity Ratio15.70 Current Ratio1.48 Quick Ratio1.05 Sales & Book Value Annual Sales$1.17 billion Price / Sales1.81 Cash Flow$12.15 per share Price / Cash Flow5.15 Book Value$1.87 per share Price / Book33.47Miscellaneous Outstanding Shares33,780,000Free Float33,484,000Market Cap$2.11 billion OptionableOptionable Beta1.12 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:NGVT) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ingevity Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ingevity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.